Pregled bibliografske jedinice broj: 1208185
Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis
Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis // The Journal of infection, 85 (2022), 2; 174-211 doi:10.1016/j.jinf.2022.04.045 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1208185 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Remdesivir use in COVID-19 patients might predispose
bacteremia, matched case-control analysis
Autori
Lucijanić, Marko ; Čikara, Tomislav ; Bistrović, Petra ; Papić, Ivan ; Ortner Hadžiabdić, Maja ; Busic, Nikolina ; Lackovic, Marina ; Cesar, Natalia ; Košćak, Valentina ; Mitrović, Joško ; Baršić, Bruno ; Lucijanić, Tomo
Izvornik
The Journal of infection (0163-4453) 85
(2022), 2;
174-211
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Remdesivir ; bacteriaemia ; covid-19
Sažetak
Severe and critical COVID-19 patients experience high frequency of bacteremia. Bacteremia might be more frequent in remdesivir treated patients. Gram positive bacteria, especially Enterococcus faecalis are of special concern. Occurrence of bacteremia moderates association of remdesivir use with survival.
Izvorni jezik
Engleski
Znanstvena područja
Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava"
Profili:
Joško Mitrović
(autor)
Maja Ortner Hadžiabdić
(autor)
Bruno Baršić
(autor)
Valentina Košćak
(autor)
Petra Bistrović
(autor)
Tomo Lucijanić
(autor)
Marko Lucijanic
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE